|
C16ORF62 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.220830E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.472380E-01 |
| Normal-vs-Stage2 |
7.458200E-01 |
| Normal-vs-Stage3 |
4.097800E-02 |
| Normal-vs-Stage4 |
2.603000E-01 |
| Stage1-vs-Stage2 |
3.225000E-01 |
| Stage1-vs-Stage3 |
3.407600E-01 |
| Stage1-vs-Stage4 |
9.340000E-01 |
| Stage2-vs-Stage3 |
1.093180E-01 |
| Stage2-vs-Stage4 |
4.431600E-01 |
| Stage3-vs-Stage4 |
4.391200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.692500E-02 |
| Normal-vs-AfricanAmerican |
8.424200E-01 |
| Normal-vs-Asian |
9.808200E-01 |
| Caucasian-vs-AfricanAmerican |
1.384810E-01 |
| Caucasian-vs-Asian |
9.380400E-02 |
| AfricanAmerican-vs-Asian |
8.173000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.505700E-02 |
| Normal-vs-Female |
1.861570E-01 |
| Male-vs-Female |
3.165200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.552000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.475230E-01 |
| Normal-vs-Age(61-80Yrs) |
1.307190E-01 |
| Normal-vs-Age(81-100Yrs) |
1.405220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.380400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.825600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.334000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.693200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.579800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.361600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.091600E-01 |
| Classical-VS-Follicular |
1.938250E-03 |
| Classical-VS-Other |
7.936200E-02 |
| Classical-VS-Normal |
5.168800E-01 |
| Tall-VS-Follicular |
3.021000E-01 |
| Tall-VS-Other |
1.995400E-01 |
| Tall-VS-Normal |
2.688800E-01 |
| Follicular-VS-Other |
5.535800E-01 |
| Follicular-VS-Normal |
1.322090E-02 |
| Other-VS-Normal |
6.994400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.425900E-02 |
| Normal-vs-N1 |
1.329920E-02 |
| N0-vs-N1 |
2.165000E-01 |
|
|
